2FIRSTS is now a Media Partner of Global Forum on Nicotine 2023

Industry InsightEvents by Parker Tang
May.10.2023
2FIRSTS is now a Media Partner of Global Forum on Nicotine 2023
2FIRSTS becomes the media partner for GFN23, set to cover the conference's proceedings in Warsaw.

On June 21, 2023, the Global Nicotine Forum 2023 (GFN23) is taking place in Warsaw, Poland. As a media partner, 2FIRSTS will provide comprehensive coverage of the conference's content.

 

2FIRSTS is a leading global vapor technology media and think tank, focusing on market trends and key issues in the global e-cigarette sector, committed to fostering global information exchange in the e-cigarette industry and aiding its growth through media influence. GFN23, the international forum focusing on safer nicotine products, covers topics related to e-cigarettes, nicotine pouches, oral tobacco products, and heated tobacco products. This collaboration will not only enhance the influence of the Global Nicotine Forum but also promote sustainable development for non-cigarette nicotine products.

 

The theme for GFN23 is "Tobacco Harm Reduction: The Next Decade." 2FIRSTS will work with GFN23 to explore the future development of the global e-cigarette industry, market trends, consumer demands, and regulatory dynamics. They will discuss the future direction of the new tobacco industry and how to promote healthier and safer e-cigarette products.

 

During the conference, 2FIRSTS plans to interview the GFN23 team or speakers and provide online coverage of the event. Individuals with management experience from tobacco companies and tech companies are also expected to attend the conference and discuss industry status and future development trends with public health officials in the tobacco control sector.

 


 

This June, the Global Forum on Nicotine (GFN) will commemorate its 10th edition with an extensive agenda that looks back at the past decade of safer nicotine use and anticipates the future. This annual forum remains the sole international conference dedicated to the role of safer nicotine products in aiding people to quit smoking and risky tobacco usage.

 

The GFN23: Tobacco harm reduction - the next decade, running from June 21 to 24, 2023, will retrospect the significant milestones of the past decade, evaluate the current complex political, regulatory, and scientific landscape, and discuss future challenges and opportunities.

 

The conference will cover a wide range of topics, including the evolution of nicotine, the politics of scientific publishing, learnings from the last decade of nicotine science, and reducing the environmental impact of tobacco harm reduction. Over fifty industry opinion leaders will contribute to panels, plenary sessions, and workshops, fostering active delegate participation and discussion.

 

Reflecting on the establishment of the conference, Professor Gerry Stimson, co-founder of the event, remains optimistic about the potential of tobacco harm reduction, despite obstacles that have surfaced over the past decade. Paddy Costall, event co-founder, praised the GFN's role in energizing and engaging individuals who use safer nicotine products, providing a platform for everyone involved in tobacco harm reduction.

2FIRSTS is now a Media Partner of Global Forum on Nicotine 2023

Registration for the event is now open, with discounted accommodation rates available until May 19. 

 

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
In H1 2026, China’s HS 24041100 exports stood at $1.32 million, down 14.3% YoY, with volume falling 17.2% to 55.33 tons. Market distribution shifted drastically amid overall export drops. Exports to Russia and Belarus totaled $1 million, taking 76.0% of all shipments versus 29.5% in H1 2025. Belarus became the top destination with export value jumping 177.5%, while the Philippines, Singapore and Indonesia’s combined share slumped from 49.3% to 11.2%.Domestically, Yunnan led exporter registrations; Jiangsu and Shanghai were key suppliers, yet Anhui and Sichuan had no exports. Heavy concentration means order or declaration changes for Russia/Belarus greatly affect national aggregate data. The data shows customs entry points (not end markets), covering tobacco consumables only, excluding heating equipment and the complete HTP supply chain.
Aug.11
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
BAT Regional Director Fred Monteiro Supports Spain’s Nicotine Rules but Opposes 0.99mg Nicotine Pouch Limit
Spanish newspaper El Confidencial interviewed Fred Monteiro, Regional Director for Americas and Europe at British American Tobacco (BAT). Monteiro said BAT supports setting regulatory limits for nicotine products but opposes Spain’s proposed 0.99mg nicotine-per-pouch limit, arguing that such a restriction could affect adult smokers’ transition to alternatives. He said nicotine regulation should be based on scientific evidence and harm reduction principles. Monteiro also said smoke-free products now account for around 25% of BAT’s Americas and Europe business and nearly 30% of its Europe business
BAT
Jul.30